Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Patent
1986-07-15
1988-02-16
Friedman, Stanley J.
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
A61K 3140
Patent
active
047256184
ABSTRACT:
The use of N-(1-allyl-2-pyrrolidinylmethyl) 2-methoxy 4-amino 5-methylsulphamoyl benzamide to treat Parkinson's disease.
REFERENCES:
patent: 3342826 (1967-09-01), Miller et al.
patent: 4263316 (1981-04-01), Thominet et al.
patent: 4405636 (1983-09-01), Perrot et al.
patent: 4499019 (1985-02-01), Thominet et al.
patent: 4550179 (1985-10-01), Perrot et al.
Besancon Denis
Costall Brenda
Jenner Peter
Marsden Charles D.
Naylor Robert J.
Friedman Stanley J.
Societe d'Etudes Scientifiques et Industrielles de l'Ile-de-Fran
LandOfFree
Use of N-(1-allyl-2-pyrrolidinylmethyl) 2-methoxy 4-amino 5-meth does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Use of N-(1-allyl-2-pyrrolidinylmethyl) 2-methoxy 4-amino 5-meth, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Use of N-(1-allyl-2-pyrrolidinylmethyl) 2-methoxy 4-amino 5-meth will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-2221480